Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial
Conditions
Interventions
3D hypoxia-preconditioned UC-MSC group
2D UC-MSC group
Locations
1
China
28 Fuxing Road, Beijing, China.
Beijing, China
Start Date
August 1, 2023
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
February 12, 2026
NCT05012111
NCT03520647
NCT04304820
NCT03579875
NCT02828592
NCT05236764
Lead Sponsor
Chinese PLA General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions